Abstract
The PIWI-interacting RNA (piRNA) pathway controls transposon expression in animal germ cells, thereby ensuring genome stability over generations. In Drosophila, piRNAs are intergenerationally inherited through the maternal lineage, and this has demonstrated importance in the specification of piRNA source loci and in silencing of I- and P-elements in the germ cells of daughters. Maternally inherited Piwi protein enters somatic nuclei in early embryos prior to zygotic genome activation and persists therein for roughly half of the time required to complete embryonic development. To investigate the role of the piRNA pathway in the embryonic soma, we created a conditionally unstable Piwi protein. This enabled maternally deposited Piwi to be cleared from newly laid embryos within 30 min and well ahead of the activation of zygotic transcription. Examination of RNA and protein profiles over time, and correlation with patterns of H3K9me3 deposition, suggests a role for maternally deposited Piwi in attenuating zygotic transposon expression in somatic cells of the developing embryo. In particular, robust deposition of piRNAs targeting roo, an element whose expression is mainly restricted to embryonic development, results in the deposition of transient heterochromatic marks at active roo insertions. We hypothesize that roo, an extremely successful mobile element, may have adopted a lifestyle of expression in the embryonic soma to evade silencing in germ cells.
Highlights
Sample-size estimation x You should state whether an appropriate sample size was computed when the study was being designed x You should state the statistical method of sample size computation and any required assumptions x If no explicit power analysis was used, you should describe how you decided what sample size to use Please outline where this information can be found within the submission
Replicates x You should report how often each experiment was performed x You should include a definition of biological versus technical replication x The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates x If you encountered any outliers, you should describe how these were handled x Criteria for exclusion/inclusion of data should be clearly stated x High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided
Statistical reporting x Statistical analysis methods should be described and justified x Raw data should be presented in figures whenever informative to do so
Summary
We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
